Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy?
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
05 May 2025
|
| In: |
Nanomedicine
Year: 2025, Jahrgang: 20, Heft: 15, Pages: 1821-1824 |
| ISSN: | 1748-6963 |
| DOI: | 10.1080/17435889.2025.2500905 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/17435889.2025.2500905 Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/full/10.1080/17435889.2025.2500905#d1e159 |
| Verfasserangaben: | Eric Mühlberg, Gert Fricker and Philipp Uhl |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1938362748 | ||
| 003 | DE-627 | ||
| 005 | 20251014124937.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251014s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/17435889.2025.2500905 |2 doi | |
| 035 | |a (DE-627)1938362748 | ||
| 035 | |a (DE-599)KXP1938362748 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Mühlberg, Eric |e VerfasserIn |0 (DE-588)1202991130 |0 (DE-627)1687644055 |4 aut | |
| 245 | 1 | 0 | |a Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy? |c Eric Mühlberg, Gert Fricker and Philipp Uhl |
| 264 | 1 | |c 05 May 2025 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.10.2025 | ||
| 650 | 4 | |a antibiotics | |
| 650 | 4 | |a Drug delivery | |
| 650 | 4 | |a nanoparticles | |
| 650 | 4 | |a resistance | |
| 650 | 4 | |a vancomycin | |
| 700 | 1 | |a Fricker, Gert |d 1956- |e VerfasserIn |0 (DE-588)1042227675 |0 (DE-627)768469465 |0 (DE-576)393783464 |4 aut | |
| 700 | 1 | |a Uhl, Philipp |e VerfasserIn |0 (DE-588)1112349391 |0 (DE-627)866420797 |0 (DE-576)476575230 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine |d London : Taylor & Francis, 2006 |g 20(2025), 15, Seite 1821-1824 |h Online-Ressource |w (DE-627)519199677 |w (DE-600)2254848-8 |w (DE-576)398100551 |x 1748-6963 |7 nnas |a Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy? |
| 773 | 1 | 8 | |g volume:20 |g year:2025 |g number:15 |g pages:1821-1824 |g extent:4 |a Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy? |
| 856 | 4 | 0 | |u https://doi.org/10.1080/17435889.2025.2500905 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.tandfonline.com/doi/full/10.1080/17435889.2025.2500905#d1e159 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251014 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1112349391 |a Uhl, Philipp |m 1112349391:Uhl, Philipp |d 160000 |d 160100 |e 160000PU1112349391 |e 160100PU1112349391 |k 0/160000/ |k 1/160000/160100/ |p 3 |y j | ||
| 998 | |g 1042227675 |a Fricker, Gert |m 1042227675:Fricker, Gert |d 160000 |d 160100 |e 160000PF1042227675 |e 160100PF1042227675 |k 0/160000/ |k 1/160000/160100/ |p 2 | ||
| 998 | |g 1202991130 |a Mühlberg, Eric |m 1202991130:Mühlberg, Eric |d 160000 |d 160100 |e 160000PM1202991130 |e 160100PM1202991130 |k 0/160000/ |k 1/160000/160100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1938362748 |e 4786968862 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy?","title":"Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy?"}],"language":["eng"],"name":{"displayForm":["Eric Mühlberg, Gert Fricker and Philipp Uhl"]},"person":[{"display":"Mühlberg, Eric","role":"aut","given":"Eric","family":"Mühlberg"},{"role":"aut","given":"Gert","display":"Fricker, Gert","family":"Fricker"},{"family":"Uhl","role":"aut","given":"Philipp","display":"Uhl, Philipp"}],"recId":"1938362748","origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"05 May 2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1080/17435889.2025.2500905"],"eki":["1938362748"]},"physDesc":[{"extent":"4 S."}],"note":["Gesehen am 14.10.2025"],"relHost":[{"disp":"Can nanoparticulate formulations of vancomycin and vancomycin derivatives improve antibiotic therapy?Nanomedicine","id":{"issn":["1748-6963"],"zdb":["2254848-8"],"eki":["519199677"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2006 -"],"origin":[{"dateIssuedKey":"2006","publisher":"Taylor & Francis ; Future Medicine Ltd","dateIssuedDisp":"2006-","publisherPlace":"London ; London"}],"recId":"519199677","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Nanomedicine","title_sort":"Nanomedicine"}],"part":{"volume":"20","year":"2025","text":"20(2025), 15, Seite 1821-1824","pages":"1821-1824","extent":"4","issue":"15"},"language":["eng"]}]} | ||
| SRT | |a MUEHLBERGECANNANOPAR0520 | ||